Literature DB >> 15802032

Japanese standard reference material JDS Lot 2 for haemoglobin A1c. II: Present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays.

Makoto Tominaga1, Hideichi Makino, Gen Yoshino, Katsuhiko Kuwa, Izumi Takei, Yukuko Aono, Tadao Hoshino, Masao Umemoto, Akira Shimatsu, Tokio Sanke, Masamichi Kuwashima, Tomohiko Taminato, Junko Ono.   

Abstract

BACKGROUND: In 2001, the Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of the Japan Diabetes Society (JDS) prepared and certified a new reference material for haemoglobin A1c (HbA1c), Lot 2. The standardization programme for HbA1c measurement in Japan is currently based on Lot 2, although some laboratories still use the previous material (Lot 1). The values assigned to Lot 2 were based on the consensus values for Lot 1 and should give the same results. Therefore, there should be no difference in the measured values no matter which calibrators are used. The Committee conducted a domestic survey in order to confirm this relationship.
METHOD: In November 2002, four samples for HbA1c assay were sent to 795 laboratories as part of a national survey in Japan. Assays were performed using the laboratories' routine clinical methods. The coefficients of variation (CVs) of the reported values from all laboratories for the samples were calculated in order to determine the current level of standardization in Japan.
RESULTS: The overall CVs in the measured values for the four samples ranged from 2.7% to 4.0%. Values from laboratories using calibrators based on Lots 1 and 2 were similar.
CONCLUSION: The present state of standardization for the routine measurement of HbA1c in Japan, as indicated by the 2002 survey, is excellent. This should aid in the eventual conversion of Lot 2 to IFCC-based values from the results of the 2002 national HbA1c survey.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802032     DOI: 10.1258/0004563053026844

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  Replacement of neutral protamine Hagedorn insulin with the long-acting insulin analogue, detemir, improves glycemic control without weight gain in basal-bolus insulin therapy in Japanese patients with type 1 diabetes.

Authors:  Taro Hayakawa; Michiyo Ishii; Megumi Watanabe; Hiroya Iwase; Asako Nishimura; Takako Monden; Kenji Kamiuchi; Motohide Isono; Nobuhito Shibata
Journal:  J Diabetes Investig       Date:  2011-01-24       Impact factor: 4.232

2.  A Method for Deriving Quasi-healthy Cohorts From Clinical Data.

Authors:  Satoshi Irino; Yukio Kurihara
Journal:  Biomed Inform Insights       Date:  2018-05-29

3.  Association of the cardioankle vascular index and ankle-brachial index with carotid artery intima media thickness in hemodialysis patients.

Authors:  Tomohito Gohda; Hiromichi Gotoh; Yoshikazu Gotoh; Saori Yamaguchi; Yasuhiko Tomino
Journal:  Int J Nephrol       Date:  2013-06-24

4.  Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients' conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study.

Authors:  Junichi Hoshino; Masanori Abe; Takayuki Hamano; Takeshi Hasegawa; Atsushi Wada; Yoshifumi Ubara; Kenmei Takaichi; Shigeru Nakai; Ikuto Masakane; Kosaku Nitta
Journal:  BMJ Open Diabetes Res Care       Date:  2020-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.